JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jansen, N. J.
Right arrow Articles by Wildevuur, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, N. J.
Right arrow Articles by Wildevuur, C. R.

The Journal of Thoracic and Cardiovascular Surgery, Vol 102, 515-525, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass

NJ Jansen, W van Oeveren, L van den Broek, HM Oudemans-van Straaten, CP Stoutenbeek, MC Joen, KJ Roozendaal, L Eysman and CR Wildevuur
Department of Cardio-Pulmonary Surgery, University Hospital, Groningen, The Netherlands.

A placebo-controlled double-blind study of patients undergoing cardiopulmonary bypass was conducted, comparing the effects of dexamethasone and a placebo on the activation of the plasmatic systems and blood cells and on the postoperative course after cardiopulmonary bypass. In the placebo group two patterns of blood activation could be distinguished. From the start of bypass, blood-material interaction caused an increase in complement C3a and elastase concentration. After release of the aortic cross-clamp, a statistically significant increase was observed in tumor necrosis factor, leukotriene B4, and tissue plasminogen activator activity (p less than 0.01, p less than 0.05, p less than 0.05, respectively). Dexamethasone treatment was not able to inhibit complement activation and elastase release during cardiopulmonary bypass. However, dexamethasone treatment effectively inhibited the increase in tumor necrosis factor, leukotriene B4, and tissue plasminogen activator activity after release of the crossclamp (p less than 0.01 compared with the placebo group). In the postoperative period the patients in the placebo group had hyperthermia and hypotension and required considerable intravenous fluid administration and cardiotonic treatment. The dexamethasone-treated patients, however, showed normothermia (p less than 0.01), had significantly higher blood pressures (p less than 0.01) without supportive treatment, and consequently were in the intensive care unit for a shorter period of time. We conclude that dexamethasone prevents the hemodynamic instability after cardiopulmonary bypass and thus improves the postoperative course by inhibition of the leukocyte and tissue plasminogen activator activity generated after release of the aortic crossclamp.


This article has been cited by other articles:


Home page
Eur Heart JHome page
R. P. Whitlock, S. Chan, P.J. Devereaux, J. Sun, F. D. Rubens, K. Thorlund, and K. H.T. Teoh
Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials
Eur. Heart J., November 1, 2008; 29(21): 2592 - 2600.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. A Hassantash, G. R Omrani, N. Givtaj, and M. Afrakhteh
Pharmacological Prevention of the Deleterious Effects of Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 218 - 224.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
T. Sano, S. Morita, M. Masuda, and H. Yasui
Minor Infection Encouraged by Steroid Administration During Cardiac Surgery
Asian Cardiovasc Thorac Ann, December 1, 2006; 14(6): 505 - 510.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. J. Liakopoulos, N. Teucher, C. Muhlfeld, P. Middel, G. Heusch, F. A. Schoendube, and H. Dorge
Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 263 - 270.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C.-H. Hsing, M.-Y. Hsieh, W.-Y. Chen, E. Cheung So, B.-C. Cheng, and M.-S. Chang
Induction of Interleukin-19 and Interleukin-22 After Cardiac Surgery With Cardiopulmonary Bypass
Ann. Thorac. Surg., June 1, 2006; 81(6): 2196 - 2201.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. J. Kozik and J. S. Tweddell
Characterizing the Inflammatory Response to Cardiopulmonary Bypass in Children
Ann. Thorac. Surg., June 1, 2006; 81(6): S2347 - S2354.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
L. Gao, R. Taha, D. Gauvin, L. B. Othmen, Y. Wang, and G. Blaise
Postoperative Cognitive Dysfunction After Cardiac Surgery
Chest, November 1, 2005; 128(5): 3664 - 3670.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. M. Morariu, B. G. Loef, L. P. H. J. Aarts, G. W. Rietman, G. Rakhorst, W. van Oeveren, and A. H. Epema
Dexamethasone: Benefit and Prejudice for Patients Undergoing On-Pump Coronary Artery Bypass Grafting: A Study on Myocardial, Pulmonary, Renal, Intestinal, and Hepatic Injury
Chest, October 1, 2005; 128(4): 2677 - 2687.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Prasongsukarn, J. G. Abel, W.R. E. Jamieson, A. Cheung, J. A. Russell, K. R. Walley, and S. V. Lichtenstein
The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: A prospective randomized trial
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 93 - 98.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. D. Rubens, H. Nathan, R. Labow, K. S. Williams, D. Wozny, J. Karsh, M. Ruel, and T. Mesana
Effects of Methylprednisolone and a Biocompatible Copolymer Circuit on Blood Activation During Cardiopulmonary Bypass
Ann. Thorac. Surg., February 1, 2005; 79(2): 655 - 665.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
B. G. Loef, R. H. Henning, A. H. Epema, G. W. Rietman, W. van Oeveren, G. J. Navis, and T. Ebels
Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass
Br. J. Anaesth., December 1, 2004; 93(6): 793 - 798.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Bourbon, M. Vionnet, P. Leprince, E. Vaissier, J. Copeland, P. McDonagh, P. Debre, and I. Gandjbakhch
The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response
Eur. J. Cardiothorac. Surg., November 1, 2004; 26(5): 932 - 938.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
R de Vroege, F te Meerman, L Eijsman, W R Wildevuur, C. R. Wildevuur, and W van Oeveren
Induction and detection of disturbed homeostasis in cardiopulmonary bypass
Perfusion, September 1, 2004; 19(5): 267 - 276.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
R. de Vroege, W. van Oeveren, J. van Klarenbosch, W. Stooker, M. A. J. M. Huybregts, C. E. Hack, L. van Barneveld, L. Eijsman, and C. R. H. Wildevuur
The Impact of Heparin-Coated Cardiopulmonary Bypass Circuits on Pulmonary Function and the Release of Inflammatory Mediators
Anesth. Analg., June 1, 2004; 98(6): 1586 - 1594.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
J. B. Celik, N. Gormus, S. Okesli, Z. I. Gormus, and H. Solak
Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: effects on TNF-{alpha}, IL-6, IL-8, IL-10
Perfusion, May 1, 2004; 19(3): 185 - 191.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Farstad, J. K. Heltne, S. E. Rynning, H. Onarheim, A. Mongstad, F. Eliassen, and P. Husby
Can the use of methylprednisolone, vitamin C, or {alpha}-trinositol prevent cold-induced fluid extravasation during cardiopulmonary bypass in piglets?
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 525 - 534.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
F D Rubens and T Mesana
The inflammatory response to cardiopulmonary bypass: a therapeutic overview
Perfusion, January 1, 2004; 19(1_suppl): S5 - S12.
[Abstract] [PDF]


Home page
Br J AnaesthHome page
L. Lindberg, C. Forsell, P. Jogi, and A.-K. Olsson
Effects of dexamethasone on clinical course, C-reactive protein, S100B protein and von Willebrand factor antigen after paediatric cardiac surgery
Br. J. Anaesth., June 1, 2003; 90(6): 728 - 732.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
M de Baar, J C Diephuis, K G M Moons, J Holtkamp, R Hijman, and C J Kalkman
The effect of zero-balanced ultrafiltration during cardiopulmonary bypass on S100b release and cognitive function
Perfusion, January 1, 2003; 18(1): 9 - 14.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Sason-Ton, R. Ben Abraham, D. Lotan, O. Dagan, T. Prince, Z. Barzilay, and G. Paret
Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children
J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. R. El Azab, P. M. J. Rosseel, J. J. de Lange, A. B. J Groeneveld, R. van Strik, E. M. van Wijk, and G. J. Scheffer
Dexamethasone decreases the pro- to anti-inflammatory cytokine ratio during cardiac surgery
Br. J. Anaesth., April 1, 2002; 88(4): 496 - 501.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
M. P Vallely, P. G Bannon, C. F Hughes, and L. Kritharides
Endothelial Cell Adhesion Molecules and Cardiopulmonary Bypass
Asian Cardiovasc Thorac Ann, December 1, 2001; 9(4): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
U. P. Schurr, G. Zund, S. P. Hoerstrup, J. Grunenfelder, F. E. Maly, P. R. Vogt, and M. I. Turina
Preoperative administration of steroids: influence on adhesion molecules and cytokines after cardiopulmonary bypass
Ann. Thorac. Surg., October 1, 2001; 72(4): 1316 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. M. Bokesch, M. B. Kapural, E. B. Mossad, M. Cavaglia, E. Appachi, J. J. Drummond-Webb, and R. B.B. Mee
Do peritoneal catheters remove pro-inflammatory cytokines after cardiopulmonary bypass in neonates?
Ann. Thorac. Surg., August 1, 2000; 70(2): 639 - 643.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J.-P. Yared, N. J. Starr, F. K. Torres, C. A. Bashour, G. Bourdakos, M. Piedmonte, J. A. Michener, J. A. Davis, and T. E. Rosenberger
Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery
Ann. Thorac. Surg., May 1, 2000; 69(5): 1420 - 1424.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. A. Bronicki, C. L. Backer, H. P. Baden, C. Mavroudis, S. E. Crawford, and T. P. Green
Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children
Ann. Thorac. Surg., May 1, 2000; 69(5): 1490 - 1495.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Ozawa, K. Yoshihara, N. Koyama, Y. Watanabe, N. Shiono, and Y. Takanashi
Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children
Ann. Thorac. Surg., February 1, 2000; 69(2): 584 - 590.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Pearl, P. B. Manning, J. L. McNamara, M. M. Saucier, and D. W. Thomas
Effect of modified ultrafiltration on plasma thromboxane B2, leukotriene B4, and endothelin-1 in infants undergoing cardiopulmonary bypass
Ann. Thorac. Surg., October 1, 1999; 68(4): 1369 - 1375.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Wan, J.-L. LeClerc, C.-H. Huynh, D. Schmartz, J.-M. DeSmet, A. P.C. Yim, and J.-L. Vincent
DOES STEROID PRETREATMENT INCREASE ENDOTOXIN RELEASE DURING CLINICAL CARDIOPULMONARY BYPASS?
J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1004 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. L. Picone, C. J. Lutz, C. Finck, D. Carney, L. A. Gatto, A. Paskanik, B. Searles, K. Snyder, and G. Nieman
Multiple sequential insults cause post-pump syndrome
Ann. Thorac. Surg., April 1, 1999; 67(4): 978 - 985.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S T Baksaas, V Videm, T E Mollnes, S Tollofsrud, G Hetland, T Pedersen, and J L Svennevig
Leucocyte filtration during cardiopulmonary bypass hardly changed leucocyte counts and did not influence myeloperoxidase, complement, cytokines or platelets
Perfusion, December 1, 1998; 13(6): 429 - 436.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Asimakopoulos and K. M. Taylor
Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
Ann. Thorac. Surg., December 1, 1998; 66(6): 2135 - 2144.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. S. Steingrub
Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 31 - 45.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. J. Gu, M. A. Mariani, W. van Oeveren, J. G. Grandjean, and P. W. Boonstra
Reduction of the Inflammatory Response in Patients Undergoing Minimally Invasive Coronary Artery Bypass Grafting
Ann. Thorac. Surg., February 1, 1998; 65(2): 420 - 424.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Ashraf, Y. Tian, D. Cowan, A. Entress, P. G. Martin, and K. G. Watterson
Release of Proinflammatory Cytokines During Pediatric Cardiopulmonary Bypass: Heparin-Bonded Versus Nonbonded Oxygenators
Ann. Thorac. Surg., December 1, 1997; 64(6): 1790 - 1794.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
S. Ashraf, Y. Tian, D. Cowan, U. Nair, R. Chatrath, N. R. Saunders, K. G. Watterson, and P. G. Martin
""Low-Dose"" Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine Release
Ann. Thorac. Surg., January 1, 1997; 63(1): 68 - 73.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
H. Mayumi, Q.-W. Zhang, A. Nakashima, M. Masuda, H. Kohno, Y. Kawachi, and H. Yasui
Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass
Ann. Thorac. Surg., January 1, 1997; 63(1): 129 - 137.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
S. Wan, J.-L. LeClerc, and J.-L. Vincent
Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation
Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Butler, V. L. Pathi, R. D. Paton, R. W. Logan, K. J. D. MacArthur, M. P. G. Jamieson, and J. C. S. Pollock
Acute-Phase Responses to Cardiopulmonary Bypass in Children Weighing Less Than 10 Kilograms
Ann. Thorac. Surg., August 1, 1996; 62(2): 538 - 542.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. Cremer, M. Martin, H. Redl, S. Bahrami, C. Abraham, T. Graeter, A. Haverich, G. Schlag, and H.-G. Borst
Systemic Inflammatory Response Syndrome After Cardiac Operations
Ann. Thorac. Surg., June 1, 1996; 61(6): 1714 - 1720.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
S. Wan, J.-M. DeSmet, M. Antoine, M. Goldman, J.-L. Vincent, and J.-L. LeClerc
Steroid Administration in Heart and Heart-Lung Transplantation: Is the Timing Adequate?
Ann. Thorac. Surg., February 1, 1996; 61(2): 674 - 678.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. E. Hill, A. Alonso, J. R. Spurzem, A. H. Stammers, and R. A. Robbins
APROTININ AND METHYLPREDNISOLONE EQUALLY BLUNT CARDIOPULMONARY BYPASS-INDUCED INFLAMMATION IN HUMANS
J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1658 - 1662.
[Abstract] [Full Text]


Home page
CirculationHome page
K. H.T. Teoh, C. A. Bradley, J. Gauldie, and H. Burrows
Steroid Inhibition of Cytokine-Mediated Vasodilation After Warm Heart Surgery
Circulation, November 1, 1995; 92(9): 347 - 353.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
R. M. Engelman, J. A. Rousou, J. E. Flack III, D. W. Deaton, R. Kalfin, and D. K. Das
Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass
Ann. Thorac. Surg., September 1, 1995; 60(3): 801 - 804.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. J. Pesonen, R. Korpela, K. Peltola, M. Leijala, H. Sairanen, K. O. Raivio, P. Venge, and S. Andersson
Regional generation of free oxygen radicals during cardiopulmonary bypass in children
J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 768 - 773.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. A. Hennein, H. Ebba, J. L. Rodriguez, S. H. Merrick, F. M. Keith, M. H. Bronstein, J. M. Leung, D. T. Mangano, L. J. Greenfield, and J. S. Rankin
Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 626 - 635.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Gadaleta, A. L. Fahey, M. Verma, W. Ko, K. H. Kreiger, O. W. Isom, and J. M. Davis
Neutrophil leukotriene generation increases after cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 642 - 647.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. D. Cooper
Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 621 - 621.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. E. Moat and P. D. MacNaughton
Routine dexamethasone therapy for cardiac operations?
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 621 - 622.
[Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. W. Boonstra, Y. J. Gu, C. Akkerman, J. Haan, R. Huyzen, and W. van Oeveren
Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 289 - 292.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Menasche, S. Haydar, J. Peynet, C. D. Buit, R. Merval, G. Bloch, A. Piwnica, and A. Tedgui
A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines
J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 293 - 299.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1991 by The American Association for Thoracic Surgery.